U.S. Urinary Catheters Market Revenue & Forecast Analysis, 2026-2035
The U.S. urinary catheters market was evaluated at USD 2.2 billion in 2025 and is projected to grow at a CAGR of 5.3% from USD 2.3 billion in 2026 to USD 3.6 billion in 2035. The robust market expansion is mainly influenced by the rising prevalence of urinary incontinence, chronic kidney diseases, neurogenic bladder disorders, and other urological conditions requiring long-term urinary management. Additionally, the growing geriatric population, increasing number of surgical procedures and hospitalisations, expanding adoption of home healthcare settings, and favorable reimbursement policies are driving the growth of the U.S. urinary catheters market.
Market Overview
The Centers for Disease Control and Prevention (CDC) reports that 15–25% of hospitalised patients in the United States receive urinary catheters during their hospital stay, underscoring the substantial demand for urinary catheter products across acute care settings.
The U.S. urinary catheters market has expanded consistently over time, driven by the increasing prevalence of urinary incontinence, benign prostatic hyperplasia (BPH), neurogenic bladder disorders, spinal cord injuries, and chronic kidney diseases. The growing geriatric population, rising hospitalisation rates, and expanding use of intermittent and indwelling catheters in both hospital and homecare settings have further supported market expansion. Additionally, advancements in hydrophilic-coated and antimicrobial urinary catheters have improved patient comfort and reduced catheter-associated urinary tract infections (CAUTIs). For instance, in 2024, BD (Becton, Dickinson and Company) continued to strengthen its urinary care portfolio with advanced catheter technologies designed to enhance infection prevention and patient outcomes across U.S. healthcare facilities.
The U.S. urinary catheters market is expected to witness substantial growth during the forecast period, owing to the increasing burden of urological disorders, expanding elderly population, and growing preference for home-based healthcare. Continuous innovations in hydrophilic and antimicrobial catheter technologies, along with rising awareness regarding self-catheterisation, are further accelerating market growth. For instance, by 2035, healthcare providers are expected to increase the adoption of next-generation urinary catheters developed by companies such as Coloplast and Convatec to improve patient outcomes and reduce infection risks.
U.S. Urinary Catheters Market Overview
Base Year Market Size (2025): USD 2.2 Billion
CAGR: 5.3%
Forecast Year Market Size (2035): USD 3.6 Billion
Major Players:
BD (Becton, Dickinson and Company)
Coloplast A/S
Teleflex Incorporated
ConvaTec Group PLC
Hollister Incorporated
U.S. Urinary Catheters Market Trends
The U.S. surgical sutures market is progressing consistently due to advancements in catheter technology, increasing prevalence of urological disorders, and a growing emphasis on infection prevention and patient comfort.
The growing adoption of hydrophilic-coated catheters is improving patient comfort and reducing urethral trauma during catheterisation procedures.
The increasing demand for antimicrobial and infection-resistant catheters is helping healthcare providers reduce the incidence of catheter-associated urinary tract infections (CAUTIs).
Advancements in catheter materials and design are enhancing flexibility, biocompatibility, and ease of use for both healthcare professionals and patients.
The rising preference for intermittent self-catheterisation and home-based urinary care is driving the demand for user-friendly and portable catheter solutions.
Furthermore, healthcare providers are increasingly focusing on reducing hospital-acquired infections and improving long-term patient outcomes through the adoption of advanced urinary management products.
Collectively, these technological advancements and the growing emphasis on patient safety, infection control, and home healthcare are expected to support the continued growth of the U.S. urinary catheters market.
U.S. Urinary Catheters Market Analysis
By Product Type
Intermittent catheters dominate the market owing to their lower infection risk and ease of use
Based on the product type, the U.S. urinary catheters market is categorised into intermittent catheters, Foley/indwelling catheters, and external catheters. The intermittent catheters segment leads the market with the highest market share in 2025.
By Material Type
Silicone catheters dominate the market owing to their biocompatibility, durability, and suitability for long-term use.
Based on the material type, the U.S. urinary catheters market is categorised into latex, silicone, PVC, hydrogel-coated, and silver-coated/antimicrobial catheters. The silicone segment dominates the market with the highest market share in 2025.
By Coating
Coated catheters lead the market due to their enhanced comfort and reduced risk of complications.
Based on the coating, the U.S. urinary catheters market is categorised into coated catheters and uncoated catheters. The coated catheters segment leads the market with the highest market share in 2025.
By Application
Urinary incontinence dominates the market due to its high prevalence and increasing treatment demand.
Based on the application, the U.S. urinary catheters market is categorised into benign prostate hyperplasia, urinary incontinence, spinal cord injury, post-surgical care, and others. The urinary incontinence segment leads the market with the highest market share in 2025.
By Gender
Male patients dominate the market owing to the high incidence of prostate-related urinary disorders.
Based on the gender, the U.S. urinary catheters market is categorised into male and female. The male segment dominates the market with the highest market share in 2025.
By End-use
Hospitals dominate the market due to the high volume of catheterisation procedures performed in clinical settings.
Based on the end-use, the U.S. urinary catheters market is categorised into hospitals, clinics, long-term care facilities, and others. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. urinary catheters market is characterized by a competitive landscape with leading urology and medical device companies competing through advanced catheter technologies, infection-prevention solutions, and patient-centric product innovations. Key players such as BD (Becton, Dickinson and Company), Coloplast A/S, Teleflex Incorporated, ConvaTec Group PLC, and Hollister Incorporated hold a significant share of the market, supported by extensive product portfolios, strong distribution networks, and continuous investments in product development.
The market is highly competitive, with companies focusing on hydrophilic-coated catheters, antimicrobial technologies, silicone-based products, and self-catheterization solutions to strengthen their market position. The growing prevalence of urinary disorders, increasing demand for home healthcare, and rising emphasis on reducing catheter-associated urinary tract infections (CAUTIs) are further intensifying competition. For instance, in 2024, BD continued to expand its urinary care portfolio with advanced catheter technologies aimed at improving patient comfort and infection prevention, reinforcing the competitive dynamics of the U.S. urinary catheters market.
U.S. Urinary Catheters Market Companies:
Some of the key companies operating in the U.S. Urinary Catheters Market include:
Abbott Laboratories
B. Braun SE
BD (Becton, Dickinson and Company)
Boston Scientific Corporation
Coloplast A/S
ConvaTec Group PLC
Cook Medical
Cardinal Health, Inc.
Edwards Lifesciences Corporation
Hollister Incorporated
J and M Urinary Catheters LLC
Medline Industries, Inc.
Medtronic plc
Teleflex Incorporated
Ur24Technology, Inc.
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. from 2021 to 2035, segmenting the U.S. urinary catheters market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Intermittent Catheters
Foley/ Indwelling Catheters
External Catheters
Material Type (Revenue in USD Million, 2021 - 2035)
Latex
Silicone
PVC
Hydrogel-coated
Silver-coated / antimicrobial catheters
Coating (Revenue in USD Million, 2021 – 2035)
Coated Catheters
Uncoated Catheters
Application (Revenue in USD Million, 2021 – 2035)
Benign Prostate Hyperplasia
Urinary Incontinence
Spinal Cord Injury
Post-Surgical Care
Others
Gender (Revenue in USD Million, 2021 – 2035)
Male
Female
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Clinics
Long-term Care Facilities
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Intermittent Catheters
4.2. Foley/ Indwelling Catheters
4.3. External Catheters
5. Market Estimates and Forecasts, By Material Type, 2021 – 2035 (USD Mn)
5.1. Latex
5.2. Silicone
5.3. PVC
5.4. Hydrogel-coated
5.5. Silver-coated / antimicrobial catheters
6. Market Estimates and Forecasts, By Coating, 2021 – 2035 (USD Mn)
6.1. Coated Catheters
6.2. Uncoated Catheters
7. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)
7.1. Benign Prostate Hyperplasia
7.2. Urinary Incontinence
7.3. Spinal Cord Injury
7.4. Post-Surgical Care
7.5. Others
8. Market Estimates and Forecasts, By Gender, 2021 – 2035 (USD Mn)
8.1. Male
8.2. Female
9. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
9.1. Hospitals
9.2. Clinics
9.3. Long-term Care Facilities
9.4. Others
10. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
10.1.1. U.S.
10.1.1.1. U.S. Surgical Sutures Market Estimates and Forecasts to 2035 (USD Mn)
10.1.1.2. Market Dynamics
10.1.1.3. Competitive Landscape
10.1.1.4. Regulatory Framework
10.1.1.5. Reimbursement Scenario
11. Competitive Landscape
11.1. Company Market Share Analysis, 2025
11.2. Company Tier Structure
11.3. List of Major Suppliers, By Key Countries
11.4. Key Company Positioning Analysis
11.5. Company Profile
11.5.1. Abbott Laboratories
11.5.2. B. Braun SE
11.5.3. BD (Becton, Dickinson and Company)
11.5.4. Boston Scientific Corporation
11.5.5. Coloplast A/S
11.5.6. ConvaTec Group PLC
11.5.7. Cook Medical
11.5.8. Cardinal Health, Inc.
11.5.9. Edwards Lifesciences Corporation
11.5.10. Hollister Incorporated
11.5.11. J and M Urinary Catheters LLC
11.5.12. Medline Industries, Inc.
11.5.13. Medtronic plc
11.5.14. Teleflex Incorporated
11.5.15. Ur24Technology, Inc.
12. Analyst Perspective
13. Related Reports
Related Research
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.